Argent Biopharma Ltd. will hold its Annual General Meeting on 28 November 2025 at Suite 1, 295 Rokeby Road, Subiaco, WA. Shareholders will receive and consider the company's annual financial report for the year ended 30 June 2025, including the Directors' declaration, the Directors' report, the Remuneration Report, and the auditor's report. Resolutions to be voted on during the meeting include the adoption of the Remuneration Report, the election of Director Gary Hermon, approval for the company to issue up to 10% of its issued capital under a 7.1A mandate, and the renewal of proportional takeover provisions in the company's constitution for a further three years.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Argent Biopharma Ltd. published the original content used to generate this news brief on October 29, 2025, and is solely responsible for the information contained therein.